Persistence of Symptoms Following Infection With COVID-19 Among Patients With Type 1 and Type 2 Diabetes Mellitus in Saudi Arabia.

Autor:	Abduljabbar MH; Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif, SAU., Alhawsawi GA; College of Pharmacy, Taif University, Taif, SAU., Aldharman SS; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU., Alshahrani KI; College of Pharmacy, Taif University, Taif, SAU., Alshehri RA; College of Pharmacy, Taif University, Taif, SAU., Alshehri AA; College of Pharmacy, Taif University, Taif, SAU., Abukhudair AT; College of Medicine, King Abdulaziz University, Rabigh, SAU., Alghamdi MA; College of Pharmacy, Taif University, Taif, SAU.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Aug 16; Vol. 15 (8), pp. e43556. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).
DOI:	10.7759/cureus.43556
Abstrakt:	Background: In Saudi Arabia, information on the persistence of COVID-19-related complications in diabetic patients, their associations with the type of diabetes mellitus (DM), and the role of uncontrolled DM in the complications remains elusive. This study aims to fill this gap. This study aimed to examine the persistence of COVID-19 complications in diabetic patients. Method: A simple randomized, cross-sectional, questionnaire-based study among patients with type 1 and 2 DM following infection with COVID-19 in Saudi Arabia. Result: In the present study, a total of 674 participants were included. Among the COVID-19 symptoms, fatigue (65.6%) was reported the most frequently, followed by headache (62.3%) and cough (59.8%). About 44% of patients reported high blood sugar levels, including 25.5% with elevated fasting (>126 mg/dL) and 18.5% with elevated postprandial (>200 mg/dL) glucose levels. We also report that age > 55 years [OR= 1.66 (1.01-2.56), p=0.045], anti-diabetic medications [OR= 2.10 (1.82-3.91), p=0.022], multiple comorbidities [OR= 3.21 (1.98-4.85), p=0.005], chest pain [OR= 2.54 (0.96-3.81), p=0.003], and joint pain [OR= 1.64 (0.73-2.94), p=0.025] were independently associated with COVID-19-related complications in diabetic patients. Conclusion: The most common persistent symptoms in diabetic patients with COVID-19 infection are fatigue, headaches, and cough. Advanced age and use of antidiabetic medications were independently associated with COVID-19-related complications in diabetic patients. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Abduljabbar et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu